Phibro Animal Health Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US71742Q1067
USD
55.48
1.68 (3.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
373.91
363.89
378.70
347.82
309.26
260.43
273.16
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
373.91
363.89
378.70
347.82
309.26
260.43
273.16
Raw Material Cost
241.59
244.55
270.82
241.94
210.53
181.96
186.39
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
13.06
13.48
0.42
13.10
13.57
12.66
9.64
Selling and Distribution Expenses
77.91
71.45
74.38
67.40
66.50
61.41
74.14
Other Expenses
-1.31
-1.35
-0.04
-1.31
-1.36
-1.27
-0.96
Total Expenditure (Excl Depreciation)
319.50
316.00
345.20
309.33
277.03
243.37
260.53
Operating Profit (PBDIT) excl Other Income
54.400000000000006
47.9
33.5
38.5
32.2
17.1
12.6
Other Income
-1.42
-2.45
-0.84
5.83
-10.92
0.69
-6.01
Operating Profit (PBDIT)
65.89
58.27
45.07
56.93
32.89
26.75
15.83
Interest
13.06
13.48
0.42
13.10
13.57
12.66
9.64
Exceptional Items
-3.51
4.31
-8.39
-1.53
-2.91
4.54
9.42
Gross Profit (PBDT)
132.32
119.35
107.88
105.89
98.73
78.47
86.78
Depreciation
12.89
12.83
12.41
12.62
11.57
9.00
9.20
Profit Before Tax
36.42
36.27
23.85
29.69
4.84
9.62
6.41
Tax
8.97
9.74
6.62
8.81
1.65
2.65
5.66
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
27.46
26.53
17.22
20.88
3.19
6.97
0.75
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
27.46
26.53
17.22
20.88
3.19
6.97
0.75
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
27.46
26.53
17.22
20.88
3.19
6.97
0.75
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
332.36
311.68
285.68
265.99
246.80
258.53
256.64
Earnings per share (EPS)
0.67
0.65
0.42
0.51
0.08
0.17
0.02
Diluted Earnings per share
0.67
0.65
0.42
0.51
0.08
0.17
0.02
Operating Profit Margin (Excl OI)
14.55%
13.16%
8.85%
11.07%
10.42%
6.55%
4.63%
Gross Profit Margin
13.19%
13.49%
9.57%
12.16%
5.31%
7.15%
5.71%
PAT Margin
7.34%
7.29%
4.55%
6.0%
1.03%
2.68%
0.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Dec 2025 is 20.89% vs 23.77% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Dec 2025 is 759.38% vs 146.15% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Dec 2025 is 53.65% vs 51.03% in Dec 2024

stock-summary

Interest

YoY Growth in quarter ended Dec 2025 is -3.68% vs 44.68% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024

Compare Quarterly Results Of Phibro Animal Health Corp. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
373.91
91.73
282.18
307.62%
Other Operating Income
0.00
0.00
0.00
Total Operating income
373.91
91.73
282.18
307.62%
Raw Material Cost
241.59
0.86
240.73
27,991.86%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
13.06
1.35
11.71
867.41%
Selling and Distribution Expenses
77.91
40.88
37.03
90.58%
Other Expenses
-1.31
0.82
-2.13
-259.76%
Total Expenditure (Excl Depreciation)
319.50
51.30
268.20
522.81%
Operating Profit (PBDIT) excl Other Income
54.41
40.43
13.98
34.58%
Other Income
-1.42
5.13
-6.55
-127.68%
Operating Profit (PBDIT)
65.89
46.07
19.82
43.02%
Interest
13.06
1.35
11.71
867.41%
Exceptional Items
-3.51
-0.85
-2.66
-312.94%
Gross Profit (PBDT)
132.32
90.87
41.45
45.61%
Depreciation
12.89
0.51
12.38
2,427.45%
Profit Before Tax
36.42
43.36
-6.94
-16.01%
Tax
8.97
0.00
8.97
Provisions and contingencies
0
0
0.00
Profit After Tax
27.46
42.94
-15.48
-36.05%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
27.46
42.94
-15.48
-36.05%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
27.46
42.94
-15.48
-36.05%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
332.36
450.12
-117.76
-26.16%
Earnings per share (EPS)
0.67
0.79
-0.12
-15.19%
Diluted Earnings per share
0.67
0.79
-0.12
-15.19%
Operating Profit Margin (Excl OI)
14.55%
44.08%
0.00
-29.53%
Gross Profit Margin
13.19%
47.82%
0.00
-34.63%
PAT Margin
7.34%
46.81%
0.00
-39.47%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 37.39 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 2.75% vs -3.91% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 20.89% vs 23.77% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 2.75 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 3.77% vs 54.07% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 759.38% vs 146.15% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.73 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 10.87% vs 32.24% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 53.65% vs 51.03% in Dec 2024

Quarterly - Interest
Interest 1.31 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -2.96% vs 3,275.00% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -3.68% vs 44.68% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.55%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024